About DURECT
DURECT is a company based in Cupertino (United States) founded in 1998 by James E. Brown was acquired by Bausch Health in July 2025.. The company has 79 employees as of December 31, 2022. DURECT operates in a competitive market with competitors including Avidity Biosciences, Flexion Therapeutics, Univercells, Sutro Biopharma and Vividion Therapeutics, among others.
- Headquarter Cupertino, United States
- Employees 79 as on 31 Dec, 2022
- Founders James E. Brown
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Durect Corporation
-
Annual Revenue
$189 K-93as on Dec 31, 2024
-
Net Profit
$-8.32 M70as on Dec 31, 2024
-
EBITDA
$-18.91 M52as on Dec 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
79
as on Dec 31, 2022
-
Acquired by
Bausch Health
(Jul 29, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of DURECT
DURECT is a publicly listed company on the NASDAQ with ticker symbol DRRX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of DURECT
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DURECT
DURECT has secured backing from 1 investor. Prominent investors backing the company include Bausch Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapeutics for multiple diseases including dermatology and neurology are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DURECT
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DURECT
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Durect Comparisons
Competitors of DURECT
DURECT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Flexion Therapeutics, Univercells, Sutro Biopharma and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Durect
Frequently Asked Questions about DURECT
When was DURECT founded?
DURECT was founded in 1998.
Where is DURECT located?
DURECT is headquartered in Cupertino, United States. It is registered at Cupertino, California, United States.
Who is the current CEO of DURECT?
James E. Brown is the current CEO of DURECT. They have also founded this company.
How many employees does DURECT have?
As of Dec 31, 2022, the latest employee count at DURECT is 79.
What is the annual revenue of DURECT?
Annual revenue of DURECT is $189K as on Dec 31, 2024.
What does DURECT do?
Developer of therapeutics for chronic diseases and pain. Commercial products include alzet osmotic pumps and absorbable polymers. It has various drug delivery platforms like a cloud, oradur, and transducer. It utilizes these technologies for its pipeline candidates which include DUR-928or chronic liver disease, posimir in the new drug application stage (NDA) for post-operative pain, remoxy in the NDA stage for chronic pain,.
Who are the top competitors of DURECT?
DURECT's top competitors include Sutro Biopharma, Flexion Therapeutics and Avidity Biosciences.
Is DURECT publicly traded?
Yes, DURECT is publicly traded on NASDAQ under the ticker symbol DRRX.
Who are DURECT's investors?
DURECT has 1 investor. Key investors include Bausch Health.
What is DURECT's ticker symbol?
The ticker symbol of DURECT is DRRX on NASDAQ.